GlassScriptPhysician profile
Howard S Rubin
NPI 1295734432
$7,965.34
in general payments reported to CMS, 2019-2025
36 companies · $1,124 in 2025
The $1,124 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $334 · 2021: $947 · 2022: $1,514 · 2023: $1,383 · 2024: $2,177 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,683.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,334.20 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $1,120.26 | 2020-2025 | Eliquis, Camzyos |
| Amgen INC. | $787.99 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $728.99 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $620.25 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $403.77 | 2021-2025 | Wainua, Farxiga |
| Medtronic, INC. | $361.07 | 2021-2025 | Onyx Frontier, Hawkone, Linq II |
| Boston Scientific Corporation | $316.27 | 2021-2025 | Watchman Flx, Accolade Sr, General - Therapies |
| Janssen Pharmaceuticals, INC | $282.94 | 2020-2022 | |
| Novo Nordisk INC | $211.78 | 2022-2025 | Wegovy |
| Biotronik INC. | $182.20 | 2020-2021 | |
| Edwards Lifesciences Corporation | $155.59 | 2021-2024 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $155.18 | 2022-2025 | Verquvo |
| Esperion Therapeutics, INC. | $139.52 | 2021-2025 | Nexletol |
| Acutus Medical, INC. | $134.64 | 2019 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.